OXY has reportedly been proven to prevent inflammation induced by LPS in microglial cells (Yuan et al., 2016), and effectively guard against experimental colitis through the AKT/Pi3K pathway (Dou et al., 2021). The gene discussed is AKT1; the disease is colitis.